Integral Health Asset Management
Latest statistics and disclosures from Integral Health Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RVMD, INSM, CYTK, CVS, EWTX, and represent 33.14% of Integral Health Asset Management's stock portfolio.
- Added to shares of these 10 stocks: CVS (+$98M), AXSM (+$65M), NVO (+$43M), EW (+$41M), ABT (+$36M), UNH (+$35M), THC (+$31M), DGX (+$30M), SYRE (+$29M), TVTX (+$21M).
- Started 29 new stock positions in MANE, INSP, TVTX, WAT, Kardigan Ord, IRTC, NVO, BIOA, ABSI, JAZZ.
- Reduced shares in these 10 stocks: RVMD (-$178M), CYTK (-$85M), AZN (-$49M), BTSG (-$49M), REGN (-$28M), Ascendis Pharma A S (-$26M), CNC (-$23M), MLYS (-$22M), FMS (-$18M), .
- Sold out of its positions in Ascendis Pharma A S, CAPR, CELC, COO, DXCM, DNTH, IRON, ELAN, EVMN, FMS.
- Integral Health Asset Management was a net seller of stock by $-20M.
- Integral Health Asset Management has $2.5B in assets under management (AUM), dropping by 21.08%.
- Central Index Key (CIK): 0001773206
Tip: Access up to 7 years of quarterly data
Positions held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 90 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 13.3 | $337M | -34% | 1.8M | 187.28 |
|
| Insmed Com Par $.01 (INSM) | 6.7 | $171M | +6% | 1.6M | 106.62 |
|
| Cytokinetics Com New (CYTK) | 5.4 | $136M | -38% | 1.6M | 85.19 |
|
| CVS Caremark Corporation (CVS) | 4.5 | $114M | +633% | 1.1M | 103.45 |
|
| Edgewise Therapeutics (EWTX) | 3.2 | $81M | +25% | 2.0M | 40.63 |
|
| Vera Therapeutics Cl A (VERA) | 3.0 | $75M | +9% | 1.8M | 42.91 |
|
| Axsome Therapeutics (AXSM) | 2.9 | $73M | +757% | 300k | 244.77 |
|
| Cardinal Health (CAH) | 2.8 | $71M | +11% | 300k | 237.56 |
|
| Roivant Sciences SHS (ROIV) | 2.8 | $71M | 2.0M | 35.39 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 2.4 | $61M | -8% | 550k | 111.03 |
|
| Edwards Lifesciences (EW) | 2.2 | $57M | +267% | 625k | 90.46 |
|
| Alignment Healthcare (ALHC) | 1.9 | $48M | -22% | 2.0M | 23.81 |
|
| Merck & Co (MRK) | 1.8 | $45M | -17% | 350k | 128.50 |
|
| Novo-nordisk A S Adr (NVO) | 1.7 | $43M | NEW | 900k | 47.94 |
|
| Quest Diagnostics Incorporated (DGX) | 1.7 | $42M | +233% | 200k | 211.95 |
|
| Uniqure Nv SHS (QURE) | 1.6 | $42M | 900k | 46.06 |
|
|
| Scholar Rock Hldg Corp (SRRK) | 1.6 | $41M | +50% | 750k | 55.00 |
|
| Boston Scientific Corporation (BSX) | 1.5 | $38M | +63% | 900k | 42.68 |
|
| Brightspring Health Svcs (BTSG) | 1.5 | $38M | -56% | 550k | 69.74 |
|
| Abbott Laboratories (ABT) | 1.4 | $36M | NEW | 400k | 90.74 |
|
| UnitedHealth (UNH) | 1.4 | $35M | NEW | 85k | 415.63 |
|
| Lifestance Health Group (LFST) | 1.3 | $32M | -30% | 3.0M | 10.71 |
|
| Novartis Sponsored Adr (NVS) | 1.2 | $31M | -20% | 200k | 156.72 |
|
| Tango Therapeutics (TNGX) | 1.2 | $31M | +122% | 1.0M | 31.26 |
|
| Tenet Healthcare Corp Com New (THC) | 1.2 | $31M | NEW | 165k | 187.08 |
|
| Spyre Therapeutics Com New (SYRE) | 1.1 | $29M | NEW | 325k | 88.78 |
|
| Definium Therapeutics Com Shs (DFTX) | 1.0 | $26M | +37% | 550k | 47.04 |
|
| Neurocrine Biosciences (NBIX) | 1.0 | $25M | 150k | 168.54 |
|
|
| Regeneron Pharmaceuticals (REGN) | 1.0 | $25M | -52% | 40k | 623.54 |
|
| Ionis Pharmaceuticals Call Option (IONS) | 0.9 | $24M | +140% | 300k | 79.29 |
|
| Biogen Idec (BIIB) | 0.9 | $22M | +66% | 100k | 216.06 |
|
| Travere Therapeutics (TVTX) | 0.8 | $21M | NEW | 375k | 56.81 |
|
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 0.8 | $21M | +52% | 190k | 110.94 |
|
| Glaukos (GKOS) | 0.8 | $21M | -14% | 150k | 139.76 |
|
| Oric Pharmaceuticals (ORIC) | 0.8 | $21M | +35% | 1.9M | 10.83 |
|
| Bridgebio Pharma (BBIO) | 0.8 | $21M | 275k | 74.48 |
|
|
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $20M | 40k | 496.73 |
|
|
| Alumis (ALMS) | 0.8 | $20M | -12% | 700k | 28.14 |
|
| Anthem (ELV) | 0.8 | $19M | -33% | 50k | 386.73 |
|
| Centene Corporation (CNC) | 0.8 | $19M | -53% | 300k | 64.19 |
|
| Erasca (ERAS) | 0.7 | $18M | +42% | 1.0M | 18.32 |
|
| Eli Lilly & Co. (LLY) | 0.7 | $18M | 15k | 1199.43 |
|
|
| Arrowhead Pharmaceuticals (ARWR) | 0.6 | $16M | -33% | 200k | 81.51 |
|
| Envista Hldgs Corp (NVST) | 0.6 | $16M | +71% | 600k | 26.35 |
|
| Medtronic SHS (MDT) | 0.6 | $16M | NEW | 200k | 78.23 |
|
| Waters Corporation (WAT) | 0.6 | $15M | NEW | 40k | 375.04 |
|
| Livanova SHS (LIVN) | 0.6 | $15M | +20% | 180k | 82.23 |
|
| Forte Biosciences Com New (FBRX) | 0.6 | $14M | +350% | 675k | 21.25 |
|
| Madrigal Pharmaceuticals (MDGL) | 0.5 | $13M | 25k | 536.95 |
|
|
| Praxis Precision Medicines I Com New (PRAX) | 0.5 | $13M | 40k | 334.79 |
|
|
| Alto Neuroscience Com Shs (ANRO) | 0.5 | $13M | 500k | 26.39 |
|
|
| Mineralys Therapeutics (MLYS) | 0.5 | $12M | -64% | 450k | 26.98 |
|
| Xenon Pharmaceuticals (XENE) | 0.5 | $12M | 200k | 60.36 |
|
|
| Ascendis Pharma A/s Ord Shs (ASND) | 0.5 | $12M | NEW | 45k | 266.72 |
|
| Acadia Healthcare (ACHC) | 0.5 | $12M | +100% | 400k | 29.53 |
|
| Irhythm Technologies (IRTC) | 0.4 | $11M | NEW | 90k | 118.95 |
|
| Biohaven (BHVN) | 0.4 | $10M | -30% | 700k | 14.88 |
|
| Beam Therapeutics (BEAM) | 0.4 | $10M | 300k | 34.32 |
|
|
| Integra Lifesciences Hldgs C Com New (IART) | 0.4 | $9.9M | NEW | 550k | 17.96 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.4 | $9.6M | NEW | 150k | 64.01 |
|
| Regenxbio Inc equity us cm (RGNX) | 0.4 | $9.6M | -46% | 800k | 11.98 |
|
| Absci Corp (ABSI) | 0.4 | $9.3M | NEW | 800k | 11.59 |
|
| Bruker Corporation (BRKR) | 0.4 | $9.0M | NEW | 150k | 60.18 |
|
| AmerisourceBergen (COR) | 0.3 | $8.5M | NEW | 30k | 282.98 |
|
| Cogent Biosciences (COGT) | 0.3 | $7.7M | -42% | 200k | 38.70 |
|
| Enliven Therapeutics (ELVN) | 0.3 | $7.6M | NEW | 150k | 50.75 |
|
| Bioage Labs (BIOA) | 0.3 | $7.4M | NEW | 300k | 24.51 |
|
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.3 | $7.2M | NEW | 30k | 240.97 |
|
| Sana Biotechnology (SANA) | 0.3 | $7.0M | -37% | 2.0M | 3.49 |
|
| Inventiva Sa Ads (IVA) | 0.2 | $5.7M | +280% | 1.5M | 3.78 |
|
| Protara Therapeutics Com Stk (TARA) | 0.2 | $5.7M | -14% | 1.5M | 3.82 |
|
| Alkermes SHS (ALKS) | 0.2 | $5.2M | NEW | 100k | 52.40 |
|
| Lb Pharmaceuticals Com Shs (LBRX) | 0.2 | $4.9M | 150k | 32.45 |
|
|
| Kardigan Ord | 0.2 | $4.8M | NEW | 200k | 23.85 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.2 | $4.7M | NEW | 50k | 93.05 |
|
| Inspire Med Sys (INSP) | 0.2 | $4.5M | NEW | 100k | 44.61 |
|
| Trevi Therapeutics (TRVI) | 0.1 | $3.7M | NEW | 200k | 18.65 |
|
| Ideaya Biosciences (IDYA) | 0.1 | $3.7M | NEW | 100k | 37.27 |
|
| Celldex Therapeutics Com New (CLDX) | 0.1 | $3.7M | NEW | 100k | 37.21 |
|
| Savara (SVRA) | 0.1 | $3.7M | 600k | 6.16 |
|
|
| Relmada Therapeutics (RLMD) | 0.1 | $3.5M | +11% | 500k | 6.92 |
|
| Mobia Med Common Stock | 0.1 | $3.4M | NEW | 250k | 13.40 |
|
| Sionna Therapeutics (SION) | 0.1 | $3.3M | +50% | 75k | 43.99 |
|
| Veradermics Common Stock (MANE) | 0.1 | $3.1M | NEW | 25k | 122.94 |
|
| Inhibikase Therapeutics Com New (IKT) | 0.1 | $2.7M | 1.4M | 2.03 |
|
|
| Rezolute Com New (RZLT) | 0.1 | $2.6M | -75% | 500k | 5.20 |
|
| Denali Therapeutics (DNLI) | 0.1 | $2.6M | NEW | 100k | 25.72 |
|
| Tenax Therapeutics Com New (TENX) | 0.1 | $2.4M | 167k | 14.55 |
|
|
| Olema Pharmaceuticals (OLMA) | 0.0 | $1.3M | -33% | 100k | 12.51 |
|
| Aura Biosciences (AURA) | 0.0 | $1.2M | NEW | 170k | 7.10 |
|
Past Filings by Integral Health Asset Management
SEC 13F filings are viewable for Integral Health Asset Management going back to 2019
- Integral Health Asset Management 2026 Q2 filed Aug. 14, 2026
- Integral Health Asset Management 2026 Q1 filed May 15, 2026
- Integral Health Asset Management 2025 Q4 filed Feb. 17, 2026
- Integral Health Asset Management 2025 Q3 filed Nov. 14, 2025
- Integral Health Asset Management 2025 Q2 filed Aug. 14, 2025
- Integral Health Asset Management 2025 Q1 filed May 15, 2025
- Integral Health Asset Management 2024 Q4 filed Feb. 14, 2025
- Integral Health Asset Management 2024 Q3 filed Nov. 14, 2024
- Integral Health Asset Management 2024 Q2 filed Aug. 14, 2024
- Integral Health Asset Management 2024 Q1 filed May 15, 2024
- Integral Health Asset Management 2023 Q3 filed Nov. 14, 2023
- Integral Health Asset Management 2023 Q2 filed Aug. 11, 2023
- Integral Health Asset Management 2023 Q1 filed May 9, 2023
- Integral Health Asset Management 2022 Q4 filed Feb. 13, 2023
- Integral Health Asset Management 2022 Q3 filed Nov. 14, 2022
- Integral Health Asset Management 2022 Q2 filed Aug. 3, 2022